| 000 | 01601 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516041342.0 | ||
| 264 | 0 | _c20120117 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1651-2057 | ||
| 024 | 7 |
_a10.2340/00015555-1113 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQuéreux, Gaëlle | |
| 245 | 0 | 0 |
_aSystemic rituximab in multifocal primary cutaneous follicle centre lymphoma. _h[electronic resource] |
| 260 |
_bActa dermato-venereologica _cSep 2011 |
||
| 300 |
_a562-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLymphoma, Follicular _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBrocard, Anabelle | |
| 700 | 1 | _aPeuvrel, Lucie | |
| 700 | 1 | _aNguyen, Jean Michel | |
| 700 | 1 | _aKnol, Anne-Chantal | |
| 700 | 1 | _aDréno, Brigitte | |
| 773 | 0 |
_tActa dermato-venereologica _gvol. 91 _gno. 5 _gp. 562-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2340/00015555-1113 _zAvailable from publisher's website |
| 999 |
_c20889799 _d20889799 |
||